PetVivo Holdings R&D Spending Growth & History (PETV)
PetVivo Holdings's r&d spending was $1.4M for fiscal 2026.
View full PetVivo Holdings company overviewPetVivo Holdings annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $1.4M | −$168,218 | −10.62% |
| 2025 | 2025-03-31 | $1.6M | $187,879 | +13.46% |
| 2024 | 2024-03-31 | $1.4M | $399,013 | +40.05% |
| 2023 | 2023-03-31 | $996,358 | $521,477 | +109.81% |
| 2022 | 2022-03-31 | $474,881 | $376,651 | +383.44% |
| 2021 | 2021-03-31 | $98,230 | $85,558 | +675.17% |
| 2020 | 2020-03-31 | $12,672 | −$188,310 | −93.69% |
| 2019 | 2019-03-31 | $200,982 | $82,042 | +68.98% |
| 2018 | 2018-03-31 | $118,940 | −$48,951 | −29.16% |
| 2017 | 2017-03-31 | $167,891 | −$709 | −0.42% |
| 2016 | 2016-03-31 | $168,600 | $164,204 | +3735.30% |
| 2015 | 2015-03-31 | $4,396 | −$75,140 | −94.47% |
| 2014 | 2014-03-31 | $79,536 | — | — |
| 2012 | 2012-03-31 | $0 | −$157,300 | — |
| 2011 | 2011-03-31 | $157,300 | — | — |
PetVivo Holdings quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $233,419 | −$107,094 | −31.45% |
| Q4 2026 | 2026-03-31 | $490,095 | $131,487 | +36.67% |
| Q3 2026 | 2025-12-31 | $322,991 | −$48,962 | −13.16% |
| Q2 2026 | 2025-09-30 | $261,433 | −$203,741 | −43.80% |
| Q1 2026 | 2025-06-30 | $340,513 | −$47,002 | −12.13% |
| Q4 2025 | 2025-03-31 | $358,608 | −$32,075 | −8.21% |
| Q3 2025 | 2024-12-31 | $371,953 | $20,369 | +5.79% |
| Q2 2025 | 2024-09-30 | $465,174 | $105,842 | +29.46% |
| Q1 2025 | 2024-06-30 | $387,515 | $93,743 | +31.91% |
| Q4 2024 | 2024-03-31 | $390,683 | −$145,478 | −27.13% |
| Q3 2024 | 2023-12-31 | $351,584 | $103,427 | +41.68% |
| Q2 2024 | 2023-09-30 | $359,332 | $218,948 | +155.96% |
| Q1 2024 | 2023-06-30 | $293,772 | $222,116 | +309.98% |
| Q4 2023 | 2023-03-31 | $536,161 | $348,923 | +186.35% |
| Q3 2023 | 2022-12-31 | $248,157 | $213,831 | +622.94% |
| Q2 2023 | 2022-09-30 | $140,384 | $24,004 | +20.63% |
| Q1 2023 | 2022-06-30 | $71,656 | −$65,281 | −47.67% |
| Q4 2022 | 2022-03-31 | $187,238 | — | — |
| Q3 2022 | 2021-12-31 | $34,326 | $4,061 | +13.42% |
| Q2 2022 | 2021-09-30 | $116,380 | — | — |
| Q1 2022 | 2021-06-30 | $136,937 | — | — |
| Q3 2021 | 2020-12-31 | $30,265 | $25,497 | +534.75% |
| Q3 2020 | 2019-12-31 | $4,768 | −$51,148 | −91.47% |
| Q2 2020 | 2019-09-30 | $7,132 | −$70,741 | −90.84% |
| Q3 2019 | 2018-12-31 | $55,916 | $39,257 | +235.65% |
| Q2 2019 | 2018-09-30 | $77,873 | $55,580 | +249.32% |
| Q4 2018 | 2018-03-31 | $56,122 | $5,466 | +10.79% |
| Q3 2018 | 2017-12-31 | $16,659 | −$25,533 | −60.52% |
| Q2 2018 | 2017-09-30 | $22,293 | −$47,253 | −67.94% |
| Q1 2018 | 2017-06-30 | $23,866 | $18,369 | +334.16% |
| Q4 2017 | 2017-03-31 | $50,656 | $27,909 | +122.69% |
| Q3 2017 | 2016-12-31 | $42,192 | $1,282 | +3.13% |
| Q2 2017 | 2016-09-30 | $69,546 | $22,039 | +46.39% |
| Q1 2017 | 2016-06-30 | $5,497 | −$51,939 | −90.43% |
| Q4 2016 | 2016-03-31 | $22,747 | — | — |
| Q3 2016 | 2015-12-31 | $40,910 | $32,252 | +372.51% |
| Q2 2016 | 2015-09-30 | $47,507 | $38,849 | +448.71% |
| Q1 2016 | 2015-06-30 | $57,436 | $48,778 | +563.39% |
| Q3 2015 | 2014-12-31 | $8,658 | −$1,824 | −17.40% |
| Q2 2015 | 2014-09-30 | $8,658 | −$95,109 | −91.66% |
| Q1 2015 | 2014-06-30 | $8,658 | — | — |
| Q3 2014 | 2013-12-31 | $10,482 | — | — |
| Q2 2014 | 2013-09-30 | $103,767 | — | — |
| Q3 2012 | 2011-12-31 | $0 | −$2,300 | — |
| Q2 2012 | 2011-09-30 | $0 | $0 | — |
| Q3 2011 | 2010-12-31 | $2,300 | — | — |
| Q2 2011 | 2010-09-30 | $0 | — | — |
PetVivo Holdings r&d spending trends
Over the last five fiscal years, PetVivo Holdings's r&d spending increased from $98,230 to $1.4M, a change of $1.3M. The latest reported quarter, Q1 2027, shows $233,419.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PetVivo Holdings source filings ↗